Incyte (INCY) Non-Current Assets (2010 - 2026)

Incyte (INCY) reported Non-Current Assets of $1.9 billion for Q1 2026, down 17.27% on a YoY basis from $2.2 billion in Q1 2025, and down 4.1% quarter-over-quarter from $1.9 billion in Q4 2025.

Incyte (INCY) Non-Current Assets (2010 - 2026) Analysis & Trends

Incyte has reported Non-Current Assets for 17 years, with the latest figure at $1.9 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 17.27% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $8.0 billion (down 8.31% YoY), and the FY2025 full-year result was $1.9 billion, down 12.3% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $1.9 billion, down from $1.9 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $2.3 billion in Q1 2024, with the low at $1.7 billion in Q3 2022.
  • Historically, Non-Current Assets has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2023.
  • Annual changes were most pronounced in 2022 — Non-Current Assets jumped 45.78% — and 2026, when it declined 17.27%.
  • Incyte's Non-Current Assets stood at $1.7 billion in 2022, then grew by 22.23% to $2.1 billion in 2023, then rose by 3.21% to $2.2 billion in 2024, then declined by 12.3% to $1.9 billion in 2025, then declined by 4.1% to $1.9 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 1.85 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Bn
Dec 31, 2025 1.93 Bn
Sep 30, 2025 2.05 Bn
Jun 30, 2025 2.18 Bn
Mar 31, 2025 2.24 Bn
Dec 31, 2024 2.21 Bn
Sep 30, 2024 2.20 Bn
Jun 30, 2024 2.09 Bn
Mar 31, 2024 2.29 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 1.99 Bn
Jun 30, 2023 1.94 Bn
Mar 31, 2023 1.83 Bn
Dec 31, 2022 1.75 Bn
Sep 30, 2022 1.69 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 1.77 Bn
Dec 31, 2021 1.81 Bn
Sep 30, 2021 1.28 Bn
Jun 30, 2021 1.28 Bn